03.07.2014
- Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...
13.06.2014
- Germany's Merck and compatriot biotech firm MorphoSys have agreed to cooperate on discovering and developing therapeutic antibodies against undisclosed immune checkpoints, that is...
06.06.2014
- Latin America continues to be an area of rising investment for the pharmaceutical industry, with Brazil and Mexico leading the way. Not only is Latin America an attractive target...
05.06.2014
- Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has begun a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for...
05.06.2014
- Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative...
15.05.2014
- AstraZeneca's chief executive Pascal Soriot said in an interview with the news agency Reuters he would engage with Pfizer if the price was right and the risks posed from forcing...
09.05.2014
- New legislation, expiring patents and increasing healthcare costs call for decisive changes in the global pharmaceutical industry. New markets for specialty medicines...
09.05.2014
- Staying in Control - IT security requires some effort. Not investing in security measures can turn out to be much more expensive than actually doing it, according to Marcel...
08.05.2014
- A Pharma Veteran's View - Dr. John L. LaMattina is the former Senior Vice President of Pfizer, and President, Pfizer Global Research and Development. In this role, Dr. LaMattina...
08.05.2014
- Changing Roles - China's far-reaching presence in the manufacture and supply of active pharmaceutical ingredients (APIs) around the world has long been known. However, with the...
